Loading...
Docoh

Biostage (BSTG)

Press releases

From Benzinga Pro
Biostage Reports Q1 2022 Financial Results and Corporate Highlights
16 May 22
Earnings, Small Cap, Press Releases
HOLLISTON, Mass., May 16, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB:BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in
Biostage Announces $5.1 Million Financing to Advance Clinical Trial
13 May 22
Small Cap, Press Releases
HOLLISTON, Mass. , May 13, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB:BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful first-in-human experience in treating
Biostage Schedules Conference Call and Webcast for Q1 2022 Results
10 May 22
Small Cap, Press Releases
HOLLISTON, Mass., May 10, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB:BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in
Biostage Further Strengthens IP Portfolio with Additional Patent for Regeneration and Repair of the Bronchus
11 Apr 22
Small Cap, Press Releases
Extends Core Intellectual Property coverage for treatment of lung cancer as well as esophageal cancer. HOLLISTON, Mass., April 11, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB:BSTG) ("Biostage" or the
Biostage Reports Fourth Quarter and Fiscal Year 2021 Financial Results
1 Apr 22
Earnings, Small Cap, Press Releases
HOLLISTON, Mass., April 1, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB:BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in
Biostage Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2021 Financial Results
30 Mar 22
Small Cap, Press Releases
HOLLISTON, Mass., March 30, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB:BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in